Purchase disclosed
Mark Lappe
Chief Executive Officer
Common Stock
- Reported value
- $328.63K
- Reported price
- $98.8659 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Inhibrx Biosciences, Inc.
Last 30 daysInsiders bought $5.5M · 3 buyers, led by Mark Lappe (CEO) with $3.64M. Sales: $279.01K by 1 insider.
Showing the first 6 of 20 trades on this page.
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
$5,098,421 of common-equity purchase value after transaction-age decay across 180 days.
3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
3 buying groups inside 30 transaction-date days, public by the snapshot cutoff.
A reporting-owner group bought on at least two distinct dates within the cluster window.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Director
Common Stock
Director
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Executive Officer | Common StockPurchase2 trades | 5,500avg $99.16 / share | $545.36K | Sep 25Filed Sep 28 · 3d later | 2 filings
|
| Chief Executive Officer | Common StockPurchase2 trades | 4,500avg $100.76 / share | $453.43K | Sep 28Filed Sep 28 · 0d later | 2 filings
|
| Director | Common StockPurchase | 5,000$100.00 / share | $500K | Sep 23Filed Sep 23 · 0d later | SEC filing |
DirectorAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Stock Option (right to buy)Grant or award | Derivative units10,000Award · no purchase price | Non-cash award | Jun 3Filed Sep 18 · 107d later | SEC filing |
DirectorAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Stock Option (right to buy)Grant or award | Derivative units10,000Award · no purchase price | Non-cash award | Jun 3Filed Sep 18 · 107d later | SEC filing |
DirectorAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Stock Option (right to buy)Grant or award | Derivative units10,000Award · no purchase price | Non-cash award | Jun 3Filed Sep 18 · 107d later | SEC filing |
DirectorAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Stock Option (right to buy)Grant or award | Derivative units10,000Award · no purchase price | Non-cash award | Jun 3Filed Sep 18 · 107d later | SEC filing |
| Director | Common StockPurchase | 5,000$100.00 / share | $500K | Sep 16Filed Sep 17 · 1d later | SEC filing |
| Director | Common StockSale | 500$111.78 / share | $55.89K | Sep 11Filed Sep 15 · 4d later | SEC filing |
| Director | Common StockSale | 500$110.26 / share | $55.13K | Sep 14Filed Sep 15 · 1d later | SEC filing |
| Director | Common StockSale | 500$105.05 / share | $52.53K | Sep 15Filed Sep 15 · 0d later | SEC filing |
| Director | Common StockSale | 500$115.14 / share | $57.57K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| Director | Common StockSale | 500$115.80 / share | $57.9K | Sep 9Filed Sep 10 · 1d later | SEC filing |
| Director | Common StockPurchase | 5,000$113.52 / share | $567.58K | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Common StockPurchase | 2,500$114.65 / share | $286.62K | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Chief Executive Officer | Common StockPurchase3 trades | 13,600avg $100.58 / share | $1.37M | Sep 8Filed Sep 8 · 0d later | 3 filings
|
Showing the latest 20 of 28 trades. Show all 28 trades
This reflects the filings imported so far, not a complete trading history.